M Heine, O Verschuren et al. Figure 1. CONSORT diagram for TREFAMS-AT trial. The light grey area marks the treatment phase. aDue b90 to use of a website and local advertisement, the exact number of potential participants reached cannot be determined. patients with MS were included; one withdrew prior to randomization due to transport issues. journals.sagepub.com/home/msj 1521https://journals.sagepub.com/home/msj